People: Synergy Pharmaceuticals Inc (SGYP.O)

SGYP.O on Consolidated Issue listed on NASDAQ Global Market

5.11USD
23 May 2013
Price Change (% chg)

$0.06 (+1.19%)
Prev Close
$5.05
Open
$5.01
Day's High
$5.13
Day's Low
$4.91
Volume
516,973
Avg. Vol
1,016,012
52-wk High
$7.44
52-wk Low
$2.98

Search Stocks

Joslyn, Alan 

Brief Biography

Dr. Alan F. Joslyn is Director of Synergy Pharmaceuticals Inc., since October 2009. Since August 2011, Dr. Joslyn has been a drug development consultant to Sentinella Pharmaceuticals. From August 2009 to August 2011 Dr. Joslyn served as the Chief Executive Officer of Edusa Pharmaceuticals, a privately held biotechnology company. From 2007 to 2009, Dr. Joslyn served as President and Chief Executive Officer of Mt. Cook Pharma and as Senior Vice President of Research & Development at Penwest Pharmaceuticals from 2004 to 2007. From 1995 to 2004, Dr. Joslyn held a number of leadership positions within Johnson & Johnson focusing on development of gastroenterology products including Propulsid®, Motilium®, Aciphex® and prucalopride. Dr. Joslyn received his B.S. in medicinal chemistry, B.A. in biology and Ph.D. in biochemical pharmacology from the State University of New York at Buffalo.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Gabriele Cerrone

2,695,400

Gary Jacob

2,695,400

Bernard Denoyer

816,443

Kunwar Shailubhai

534,842

Alan Joslyn

--

Thomas Adams

--
As Of 30 Dec 2012
Search Stocks